Cooperative Agreement NU58DD000006

The Indiana Department of Health (IDOH) has been awarded a $279,612 Cooperative Agreement under the Centers for Disease Control and Prevention's (CDC) Sexually Transmitted Diseases (STD) Prevention and Control Grants program (CFDA 93.977). The funding will support IDOH's efforts to conduct sentinel and enhanced STI surveillance to recover critical data missed in routine case reporting or unavailable from other sources. This will improve IDOH's ability to address STI/HIV health equity outcomes...

The U.S. Centers for Disease Control and Prevention (CDC) awarded a $1,300,796 Cooperative Agreement under the Disabilities Prevention Grant Program (CFDA 93.184) to Trustees of Indiana University (Indiana University) to advance surveillance of congenital heart defects (CHD) through unparalleled informatics and data science. The project aims to: (1) employ methods to identify CHD cases among children, adolescents, and adults in Indiana; (2) integrate comprehensive clinical and administrative...

This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $254,604 to Dana-Farber Cancer Institute, Inc. to develop and implement a community-based collaborative care model to deliver a resilience-focused intervention for adolescents and young adults with non-malignant blood disorders, such as sickle cell disease. The 5-year project aims to (1) assess the feasibility and acceptability of the...

The Indiana Department of Health was awarded a $500,000 Cooperative Agreement from the Centers for Disease Control and Prevention (CDC) under the HIV Prevention Activities Health Department Based (CFDA 93.940) federal grant program. The award, effective September 1, 2024 through August 31, 2027, will fund the implementation of the REACH (Rural Re-Engagement and Care Using CHWs for Persons with HIV) program. REACH aims to improve HIV care services in Indiana's rural communities by employing a...

This Project Grant awarded by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) provides $156,340 in funding to Connecticut Children's Medical Center to develop and test a communication-enhancement intervention for healthcare providers (HCPs) to improve health outcomes in pediatric sickle cell disease (SCD) patients. The 5-year award period runs from June 15, 2025 to May 31, 2030. The key activities include refining an...

This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), will fund the implementation and pilot-testing of an integrated sickle-cell screening and violence prevention program in antenatal care settings in India. The $167,560 award to the Trustees of Boston University, Massachusetts will be used to: 1) conduct formative research to inform the adaptation of the Jamii Bora intervention, 2) adapt the...

This Project Grant award of $444,125 from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) supports research at Duke University to investigate the impact of red cell exchange (RCE) procedures on neutrophil function in sickle cell disease (SCD) patients. The research aims to determine if RCE, which replaces abnormal sickle hemoglobin red blood cells with normal hemoglobin cells, can modulate neutrophil reactivity and function,...

This Cooperative Agreement award of $1,701,687.00 from the Centers for Disease Control and Prevention (CDC) under the CDC Investigations and Technical Assistance program (CFDA 93.283) is intended to support the "Advancing Health Equity in Asthma Control Through EXHALE Strategies" project. The project aims to improve asthma control and reduce health disparities, with a focus on communities in Indiana. The prime awardee is the Indiana Department of Health, which will collaborate with two...

This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training (CFDA 93.859) program provides $272,856 to Emory University to implement the "ELEVATING MENTORING POSSIBILITIES FOR OVERCOMING WITHSTANDING EDUCATIONAL ROADBLOCKS IN SICKLE CELL DISEASE (EMPOWER SCD): STEMM MENTORING FOR YOUTH WITH SICKLE CELL DISEASE" project over a 5-year period starting September 1, 2024. The project aims to use...

The Department of Health and Human Services Health Resources and Services Administration (HRSA) awarded a $300,000 Project Grant under the Ryan White HIV/AIDS Program HIV-Related Training and Technical Assistance (CFDA 93.145) to The Damien Center Inc., a non-profit organization in Indianapolis, Indiana. The grant will support comprehensive educational and capacity-building initiatives designed to enhance HIV prevention, care, and treatment services across the United States from September 1,...